|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.51 CAD | 0.00% |
|
+0.12% | -7.70% |
| Apr. 22 | BioSyent Inc.(TSXV:RX) dropped from S&P/TSX Venture Composite Index | CI |
| Apr. 01 | BioSyent To Present At LD Micro New York Investor Conference | MT |
BioSyent Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CAD 31.59 million compared to CAD 27.93 million a year ago. Net income was CAD 6.46 million compared to CAD 5.46 million a year ago.
Basic earnings per share from continuing operations was CAD 0.541 compared to CAD 0.444 a year ago. Diluted earnings per share from continuing operations was CAD 0.531 compared to CAD 0.435 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -7.70% | 72.15M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
BIOSYENT INC. 
